Skip to main content

6 Result(s)

within J. -P. Lefranc Remove this filter

and

  1. No Access

    Chapter and Conference Paper

    Ki-67 : niveau de preuve et considérations méthodologiques pour son utilisation dans la décision thérapeutique — revue analytique et critique

    Les cliniciens souhaitent disposer de biomarqueurs sélectionnant les patientes porteuses d’un cancer du sein RE+ qui pourraient ne pas recevoir de chimiothérapie. Le degré de prolifération cellulaire est un él...

    E. Luporsi, F. André, F. Spyratos… in Cancer du sein : surdiagnostic, surtraitem… (2012)

  2. No Access

    Article

    Recommandations pour la pratique clinique: Standards, Options: Recommandations 2007 pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l’ovaire. Traitement chirurgical (rapport abrégé)

    La mise à jour de ces recommandations a été élaborée par la Fédération nationale des centres de lutte contre le cancer (FNCLCC) en partenariat avec les secteurs public, privé et l’Institut national du cancer.

    P. Morice, F. Planchamp, E. Daraï, E. Leblanc, J. -P. Lefranc, D. Querleu… in Oncologie (2008)

  3. Article

    Open Access

    Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients

    Study of the prognostic impact of multidrug resistance gene expression in the management of breast cancer in the context of adjuvant therapy. This study involved 171 patients treated by surgery, adjuvant chemo...

    L Moureau-Zabotto, S Ricci, J P Lefranc, F Coulet, C Genestie… in British Journal of Cancer (2006)

    Download PDF (155 KB) View Article

  4. No Access

    Article

    Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer

    Purpose. To assess the significance of S-phase fraction (SPF) and DNA ploidy evaluated by DNA flow cytometry as prognostic markers in stage I or II breast cancer.

    L. Moureau-Zabotto, C. Bouchet, D. Cesari, S. Uzan… in Breast Cancer Research and Treatment (2005)

  5. No Access

    Chapter

    Breast cancer

    In France, as in the majority of industrialized countries, cancer of the breast is the commonest cancer in women. There has been a constant increase in its incidence over last 30 years, and it is the major cau...

    E.-Ch. Antoine, O. Rixe, P. Pouillart, N. Renody… in CT and MRI in Oncology (1998)

  6. No Access

    Chapter and Conference Paper

    Follow-up of treated gynecologic cancer: CT and MRI contribution

    We present the result of a study on the interest of CT and MRI for the following of gynecologic cancer after treatment, compared with clinical, surgical and histological data.

    D. Buthiau, D. Khayat, D. Nizri… in Proceedings of the 3rd International Congr… (1991)